Moreover, among subjects without active replication of HCV, we could not demonstrate an association between hepatic steatosis and IL28B genotype, indicating that the lipid metabolism disturbance observed in CT/TT patients with chronic HCV infection requires the presence of actively replicating HCV virus to occur. This evidence concerns the gene IFNL3 and Hepatic steatosis.